(GRCL) – Management Comments
-
Gracell Biotechnologies (GRCL) Reports Q4; Provides Corporate Update
-
Gracell Biotechnologies (GRCL) Reports First Patient Enrollment in Registrational Phase 1/2 Clinical Study for GC007g
-
Back to GRCL Stock Lookup